Results 1 to 10 of about 669,979 (252)
The genetics of interstitial lung diseases [PDF]
European Respiratory Review, 2019 Interstitial lung diseases (ILDs) are a set of heterogeneous lung diseases characterised by inflammation and, in some cases, fibrosis. These lung conditions lead to dyspnoea, cough, abnormalities in gas exchange, restrictive physiology (characterised by ...
Raphaël Borie +7 more
semanticscholar +5 more sources
Comorbidities in interstitial lung diseases [PDF]
European Respiratory Review, 2017 Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients can die because of the progression of their illness, remain stable or even improve after appropriate treatment has been instituted.
G. Margaritopoulos +2 more
semanticscholar +5 more sources
Smoking and interstitial lung diseases [PDF]
European Respiratory Review, 2015 For many years has been well known that smoking could cause lung damage. Chronic obstructive pulmonary disease and lung cancer have been the two most common smoking-related lung diseases.
G. Margaritopoulos +4 more
semanticscholar +4 more sources
Interstitial lung disease [PDF]
European Respiratory Review, 2014 Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Ulrich Costabel +10 more
openaire +6 more sources
Interstitial lung disease [PDF]
European Respiratory Review, 2013 This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.Since the recent international guidelines for the management of idiopathic pulmonary fibrosis (IPF), important new evidence is ...
Ariozzi I. +4 more
openaire +7 more sources
Telomeres in Interstitial Lung Disease [PDF]
Journal of Clinical Medicine, 2021 Interstitial lung diseases (ILD) encompass a group of conditions involving fibrosis and/or inflammation of the pulmonary parenchyma. Telomeres are repetitive DNA sequences at chromosome ends which protect against genome instability. At each cell division, telomeres shorten, but the telomerase complex partially counteracts progressive loss of telomeres ...
Stock, C, Renzoni, E
openaire +5 more sources
Arthritis & Rheumatology, 2022 To analyze the efficacy and safety of nintedanib in patients with fibrosing autoimmune disease–related interstitial lung diseases (ILDs) with a progressive phenotype.
E. Matteson +14 more
semanticscholar +1 more source
Lung transplantation for interstitial lung disease [PDF]
European Respiratory Review, 2021 Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD.
Siddhartha G. Kapnadak, Ganesh Raghu
openaire +3 more sources
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
International Journal of Molecular Sciences, 2021 Interstitial lung diseases (ILDs) comprise different fibrotic lung disorders characterized by cellular proliferation, interstitial inflammation, and fibrosis.
P. Montero +3 more
semanticscholar +1 more source
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis
Respiratory Research, 2022 Background Advanced pulmonary sarcoidosis causes significant morbidity and can lead to death. Large trials demonstrated efficacy of antifibrotics in patients with progressive fibrosing interstitial lung diseases (PF-ILD), including a few with sarcoidosis.
M. C. Schimmelpennink +7 more
doaj +1 more source